Log in
Enquire now
‌

US Patent 11944607 Treatment of progressive neurodegenerative disease with ibudilast

Patent 11944607 was granted and assigned to MediciNova on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
MediciNova
MediciNova
0
Current Assignee
MediciNova
MediciNova
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119446070
Patent Inventor Names
Kazuko Matsuda0
Richard E. Gammans0
Michael E. Kalafer0
Kenneth W. Locke0
Date of Patent
April 2, 2024
0
Patent Application Number
173665630
Date Filed
July 2, 2021
0
Patent Primary Examiner
‌
Jeffrey S Lundgren
0
Patent abstract

Compositions and methods for treating progressive neurodegenerative diseases, and their associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11944607 Treatment of progressive neurodegenerative disease with ibudilast

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.